# PK/PD Data Assessment & System Readiness

## Executive Summary

‚úÖ **System is FUNCTIONAL for testing** with current data sources, but has **LIMITATIONS** for complete PK/PD analysis.

---

## Current Data Coverage

### ‚úÖ What We Have (Working Well)

1. **Pharmacodynamics (PD) - EXCELLENT**
   - ‚úÖ **Protein Targets**: 32 targets per drug from BIO index (e.g., warfarin=32, fluconazole=32)
   - ‚úÖ **Target Overlap Detection**: Working (common targets identified)
   - ‚úÖ **DrugBank Targets**: Fallback from DuckDB when QLever unavailable
   - **Status**: Sufficient for PD analysis

2. **Real-World Signals - EXCELLENT**
   - ‚úÖ **TwoSides PRR**: Pair interaction scores (e.g., warfarin+fluconazole=120.0)
   - ‚úÖ **Side Effects**: 25 per drug from TwoSides
   - ‚úÖ **Risk Scores**: DILI, DICT, DIQT from DuckDB
   - ‚úÖ **FAERS Data**: 10 reactions per drug + combo from OpenFDA
   - **Status**: Comprehensive real-world evidence

3. **Drug Identification - GOOD**
   - ‚úÖ **PubChem CIDs**: Retrieved from CORE index
   - ‚úÖ **Synonyms**: Available
   - **Status**: Sufficient

### ‚ö†Ô∏è What's Missing (Critical Gaps)

1. **Pharmacokinetics (PK) - CRITICAL GAP**
   - ‚ùå **Enzyme Roles**: Empty (substrate/inhibitor/inducer not found)
   - ‚ùå **CYP Enzymes**: Found in BIO index but can't extract standard names (CYP3A4, CYP2C9, etc.)
   - ‚ùå **Transporter Data**: Not queried
   - **Impact**: **Cannot detect PK interactions** (inhibition, induction, competition)
   - **Reason**: 
     - PubChem CORE index doesn't have enzyme role attributes
     - BIO index has CYP proteins but:
       - Protein IDs are non-standard (e.g., `ACCYP_401673` vs `CYP3A4`)
       - No role information (substrate/inhibitor/inducer)
       - Need external mapping or different data source

2. **Disease Associations - MINOR GAP**
   - ‚ùå **Disease Links**: Empty (0 diseases found)
   - **Impact**: Low - diseases are nice-to-have but not critical for DDI analysis
   - **Reason**: Disease index may not have direct compound-disease links in expected format

---

## Why Enzymes Are Empty

### Root Cause Analysis

1. **CORE Index**: 
   - ‚úÖ Has compound attributes (23 found for fluconazole)
   - ‚ùå **No CYP enzyme attributes** in expected format
   - ‚ùå No `sio:SIO_000008` attributes with CYP information

2. **BIO Index**:
   - ‚úÖ **Has CYP proteins** (10 found for fluconazole: `ACCYP_401673`, `ACCYP_003708382`, etc.)
   - ‚ùå **Non-standard naming**: IDs like `ACCYP_401673` don't map to `CYP3A4`
   - ‚ùå **No role information**: Can't tell if substrate/inhibitor/inducer
   - ‚ùå **No labels/identifiers**: Most proteins have no `rdfs:label` or `dcterms:identifier`

3. **Data Structure Mismatch**:
   - PubChem RDF stores enzymes as **proteins in bioactivity data**
   - But doesn't encode **metabolic roles** (substrate/inhibitor/inducer)
   - Need **external knowledge base** (e.g., DrugBank, ChEMBL) for role information

---

## PK/PD Requirements vs Current State

### For Complete PK/PD Analysis, We Need:

| Component | Required | Current Status | Gap |
|-----------|----------|----------------|-----|
| **PK: Enzyme Substrates** | ‚úÖ Critical | ‚ùå Empty | **HIGH** |
| **PK: Enzyme Inhibitors** | ‚úÖ Critical | ‚ùå Empty | **HIGH** |
| **PK: Enzyme Inducers** | ‚úÖ Critical | ‚ùå Empty | **HIGH** |
| **PK: Transporters** | ‚ö†Ô∏è Important | ‚ùå Not queried | **MEDIUM** |
| **PD: Protein Targets** | ‚úÖ Critical | ‚úÖ 32 per drug | **NONE** |
| **PD: Pathways** | ‚ö†Ô∏è Nice-to-have | ‚ùå Empty (reserved) | **LOW** |
| **Real-World: PRR** | ‚úÖ Critical | ‚úÖ Working | **NONE** |
| **Real-World: FAERS** | ‚úÖ Critical | ‚úÖ Working | **NONE** |
| **Risk Scores: DILI/DICT/DIQT** | ‚úÖ Important | ‚úÖ Working | **NONE** |

### Current PK/PD Capabilities

**What We CAN Do:**
- ‚úÖ Detect **PD interactions** (target overlap)
- ‚úÖ Provide **real-world signals** (PRR, FAERS)
- ‚úÖ Assess **risk scores** (DILI, DICT, DIQT)
- ‚úÖ Identify **drugs** and **synonyms**

**What We CANNOT Do:**
- ‚ùå Detect **PK interactions** (inhibition, induction, competition)
- ‚ùå Predict **exposure changes** (‚Üë or ‚Üì drug levels)
- ‚ùå Identify **metabolic pathways**
- ‚ùå Warn about **CYP-mediated interactions**

---

## Recommendations

### Option 1: Use External Enzyme Data (RECOMMENDED)
**Integrate DrugBank or ChEMBL for enzyme roles:**
- DrugBank XML (already in DuckDB) may have enzyme data
- Query DrugBank for CYP substrate/inhibitor/inducer information
- Merge with QLever target data

### Option 2: Improve BIO Index Extraction
**Better CYP name extraction from protein IDs:**
- Map `ACCYP_401673` ‚Üí `CYP3A4` using lookup table
- Extract from protein identifiers more intelligently
- Still won't get roles (substrate/inhibitor/inducer)

### Option 3: Accept Limitation
**Document that PK analysis is limited:**
- System works well for **PD interactions** and **real-world signals**
- PK interactions require manual review or external sources
- Still valuable for clinical decision support

---

## System Readiness Assessment

### ‚úÖ GREEN LIGHT FOR TESTING - With Caveats

**The system is READY for testing IF:**

1. **Primary Use Case**: PD interactions + real-world signals
   - ‚úÖ System is **excellent** for this
   - ‚úÖ Targets, PRR, FAERS all working

2. **Secondary Use Case**: Complete PK/PD analysis
   - ‚ö†Ô∏è System is **limited** for this
   - ‚ùå PK interactions won't be detected
   - ‚ö†Ô∏è Need to supplement with external enzyme data

3. **Clinical Use**: 
   - ‚ö†Ô∏è **Not ready** for unsupervised clinical use
   - ‚úÖ **Ready** for research/testing with clear limitations documented

### Recommendations for Production

1. **Short Term** (Current State):
   - ‚úÖ Test system with focus on **PD interactions** and **real-world signals**
   - ‚ö†Ô∏è Document PK limitations clearly in UI
   - ‚úÖ Use for **research/validation** purposes

2. **Medium Term** (Improvements Needed):
   - üîß Integrate DrugBank enzyme data from DuckDB
   - üîß Add transporter queries to BIO index
   - üîß Improve CYP name extraction from protein IDs

3. **Long Term** (Full PK/PD):
   - üîß Integrate ChEMBL or other enzyme knowledge bases
   - üîß Add pathway queries to DISEASE or CORE index
   - üîß Build enzyme role inference from bioactivity data

---

## Test Results Summary

### 5 Drug Pairs Tested: ‚úÖ 5/5 Successful

| Pair | Targets | Enzymes | PRR | FAERS | Status |
|------|---------|---------|-----|-------|--------|
| warfarin + fluconazole | 32+32 | 0+0 | 120.0 | ‚úÖ | ‚úÖ |
| aspirin + ibuprofen | 32+32 | 0+0 | 160.0 | ‚úÖ | ‚úÖ |
| metformin + insulin | 32+0 | 0+0 | None | ‚úÖ | ‚úÖ |
| atorvastatin + amiodarone | 32+32 | 0+0 | 90.0 | ‚úÖ | ‚úÖ |
| digoxin + furosemide | 32+0 | 0+0 | 252.7 | ‚úÖ | ‚úÖ |

**Total Targets Retrieved**: 256  
**Total Enzymes Retrieved**: 0  
**Pairs with PRR**: 4/5  
**Pairs with FAERS**: 5/5  

---

## Conclusion

**The system is FUNCTIONAL and READY for testing**, but with **clear limitations**:

‚úÖ **Strengths**: PD analysis, real-world signals, risk assessment  
‚ùå **Weaknesses**: PK analysis (enzyme roles missing)  
‚ö†Ô∏è **Recommendation**: Proceed with testing, document limitations, plan enzyme data integration

**For PK/PD completeness**: Need to integrate external enzyme knowledge base (DrugBank/ChEMBL).

